drugset / Trial / NCT02568878

Creatine for Depressed Male and Female Methamphetamine Users

NCT02568878

Phase 3 Recruiting 29 enrolled Montana State University
NaSingle-groupOpen-labelTreatment

Summary

* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression

Timeline

Start
2015-11
Primary completion
2016-10
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified 5 g Oral